| NCT ID | NCT05434637 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Tinnitus |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2023-11-01 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2023-11-01 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to learn more about a type of tinnitus (ringing in the ears) known as "somatosensory tinnitus." This type of tinnitus is suspected when the tinnitus perception changes following head and/or neck movements. This study is also exploring a possible way to treat somatosensory tinnitus.
Eligibility Criteria
Inclusion Criteria: * Constant, chronic tinnitus (6-months in duration) * bothersome tinnitus based on TFI score and self-reported loudness * able to modulate tinnitus perception with head, neck, and/or jaw maneuvers Exclusion Criteria: * Middle ear pathology * not a candidate for physical therapy * injury to the temporomandibular area in past 3 months * active pathology in the orofacial region
Contact & Investigator
Sarah Theodoroff, PhD
PRINCIPAL INVESTIGATOR
VA Portland Health Care System, Portland, OR
Frequently Asked Questions
Who can join the NCT05434637 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tinnitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05434637 currently recruiting?
Yes, NCT05434637 is actively recruiting participants. Contact the research team at Sarah.Theodoroff@va.gov for enrollment information.
Where is the NCT05434637 trial being conducted?
This trial is being conducted at Portland, United States.
Who is sponsoring the NCT05434637 clinical trial?
NCT05434637 is sponsored by VA Office of Research and Development. The principal investigator is Sarah Theodoroff, PhD at VA Portland Health Care System, Portland, OR. The trial plans to enroll 72 participants.